Senior insider sale
Chief Executive Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$3.11M
79.78K shares
What this filing means
BARROW ROBERT plans to sell 79.78K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $3.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2026ACC: 0001950047-26-009813
DirectorOfficer· Chief Executive Officer
Since Jan 2022
79.78K
Shares to sell
$3.11M
Approx. market value
31.55K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
9/25/2026
31.55KTotal acquired31.55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 31.55K | — |
| Total | 31.55K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
19.02K
Market value
$718.1K
9/3/2026
—Completed
Units to sell
29.21K
Market value
$1.23M
6/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
31.55K
Market value
$1.16M
9/25/2026
Total
Units
79.78K
Value
$3.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/3/2026 | 19.02K | $718.1K | — | Completed |
6/25/2026 | 29.21K | $1.23M | — | Completed |
| Planned — Approximate Date | ||||
9/25/2026 | 31.55K | $1.16M | NASDAQ | Planned |
| Total | 79.78K | $3.11M | ||